Thyroid RFA Practice Guidelines

The use of ultrasound-guided ablation procedures to treat both benign and malignant thyroid conditions is gaining increasing interest. More and more international interdisciplinary evidence-based statements with a primary focus on radiofrequency ablation have been developed.

2025


2023


USA

General principles for the safe performance, training, and adoption of ablation techniques for benign thyroid nodules: an american thyroid association statement

The primary goal of this interdisciplinary consensus statement is to provide a framework for the safe adoption and implementation of ablation technologies for benign thyroid nodules.

2024


USA

Radiofrequency ablation of thyroid nodules: “good clinical practice recommendations” for austria

2020


An interdisciplinary statement from the following professional associations: Austrian Thyroid Association (ÖSDG), Austrian Society for Nuclear Medicine and Molecular Imaging (OGNMB), Austrian Society for Endocrinology and Metabolism (ÖGES), Surgical EndocrinologyWorking Group (ACE) of the Austrian Surgical Society (OEGCH)

USA

AUS

Thyroid radiofrequency ablation guideline: korean society of thyroid radiology

2022


USA

Thermal ablation using radiofrequency is a new, minimally invasive modality employed as an alternative to surgery in patients with benign thyroid nodules and recurrent thyroid cancers. The Task Force Committee of the Korean Society of Thyroid Radiology (KSThR) developed recommendations for the optimal use of radiofrequency ablation for thyroid tumors in 2012. As new meaningful evidences have accumulated, KSThR decided to revise the guidelines. The revised guideline is based on a comprehensive analysis of the current literature and expert consensus.

2024


USA

American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Association Medici Endocrinology, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association

An international multidisciplinary consensus statement: radiofrequency ablation and related ultrasound-guided ablation technologies for the treatment of benign and malignant thyroid disease

2020

EUR


European thyroid association clinical practice guideline for the use of imaging-guided ablation in benign thyroid nodules

2017


To provide the best scientific evidence available and a consensus expert opinion regarding the use of RFA of the thyroid in clinical practice.

KOR

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer

Differentiated thyroid cancer (DTC) is the most prevalent cancer of thyroid and is among the most frequently diagnosed cancers in the United States. The practice guidelines of the American Thyroid Association (ATA) for DTCmanagement in adult patients (previously combined with thyroid nodules) were published initially in 1996, with subsequent revisions based on advances in the field. The goal of this update is to provide clinicians, patients, researchers, and those involved in health policy with rigorous, comprehensive, and contemporaryguidelines to assist in the management of adult patients with DTC, emphasizing the patient journey beginning with a thyroid cancer diagnosis.

Radiofrequency ablation of thyroid nodules

Thyroid nodules are common in the general population and can cause symptoms in some patients. Surgical resection is the current standard of care, but radiofrequency ablation has become more popular. The indications, pre-operative considerations, procedural principles, and postoperative care are discussed

Basic physics and equipment for radiofrequency ablation

Percutaneous thermal ablation is a widely accepted technique to ablate tissues within the body. Various thermal ablation modalities are readily available. For thyroid ablation, radiofrequency ablation (RFA) is the most established modality to date. The physics behind RFA technology, tissue hyperthermia and necrosis, and equipment for thyroid RFA is described